BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Emerging Biotech

Australia Allows Prescription of MDMA and Psilocybin in Groundbreaking Regulatory Change

PharmAla Biotech Holdings Inc. (“PharmAla”)(CSE: MDMA) applauds the Australian Therapeutic Goods Administration (TGA) in allowing for spec...

February 03, 2023 | News

Biosynex and Chembio Diagnostics Announce Definitive Acquisition Agreement

Consolidated Manufacturing, Sales, Marketing, Operations to Provide Synergistic Cost Savings Biosynex SA (“Biosynex”) (EPA: ALBIO), a French m...

February 01, 2023 | News

Duoning Headquarters in Fengxian Biotechnology Park with Centers for R&D and Technology Applications

The global headquarters, R&D center, and TAC are located in the heart of the Biotechnology Park, with a total planned area of 20,029.8 m2. It...

January 31, 2023 | News

GeneDx Makes Significant Industry-Wide Contributions to New Disease Gene Discovery

Throughout 2022, GeneDx (Nasdaq: WGS), a leader in delivering improved health outcomes through genomic and clinical insights, contributed a significant amo...

January 31, 2023 | News

Singleron launches single cell eQTL analysis as part of their sequencing service

Bioinformatic experts at Singleron Biotechnologies, a leader in single cell sequencing, have developed a new single cell eQTL analysis workflow that t...

January 26, 2023 | News

Metabolon Secures $25 Million of Funding to Accelerate Growth

The proceeds will be used for general corporate purposes, helping Metabolon further accelerate commercialization activities and continue advancing its well...

January 25, 2023 | News

AstraZeneca Begins Tender Offer to Acquire CinCor Pharma, Inc.

On 9 January 2023, AstraZeneca announced that it had entered into a definitive agreement to acquire CinCor. Following the successful closing of the tender ...

January 23, 2023 | News

KBI Biopharma Announces Subcontract with Mapp Biopharmaceutical on Sudan ebolavirus Treatment

KBI Biopharma, Inc. (KBI), a JSR Life Sciences company, today announced it entered into a subcontract with Mapp Biopharmaceutical, Inc. (Mapp) for the cont...

January 23, 2023 | News

Pioneering research from UAE students driving the future of the region’s healthcare industry

Arab Health to support the next generation of healthcare specialists in the region with the launch of the Future Doctor Programme for undergradua...

January 23, 2023 | News

German pharma company selects Generis’ CARA Life Sciences Platform to unify their clinical processes

Cheplapharm were looking for a solution to enable them to move away from manual data processes and using multiple separate systems including Excel, which l...

January 19, 2023 | News

FAPON presents at 41st Annual J.P. Morgan Healthcare Conference

FAPON focuses on three business lines: raw materials and solutions, the IVD ecosystem, and intelligent digital diagnosis & treatment. Supported by its ...

January 17, 2023 | News

Juniper Biologics Partners With Caris Life Sciences® for Molecular Profiling Distribution in South East Asia

The company's suite of market-leading molecular profiling offerings assess DNA, RNA and proteins to reveal a molecular blueprint that helps patients, physi...

January 12, 2023 | News

BioVersys Extends its Series C Round to CHF 32.6 Million with Investment from the AMR Action Fund

BioVersys AG, a privately held clinical stage, multi-asset Swiss pharmaceutical company focusing on research and development of therapies for life-th...

January 06, 2023 | News

Duality Biologics Announces License Agreement of its Next-generation ADC platform with Adcendo

Duality to grant license of DITAC (Duality Immune Toxin Antibody Conjugates) platform to Adcendo for its lead uPARAP ADC program Duality to receive upfr...

January 05, 2023 | News

Stay Connected